再生元製藥公司 REGN 深 滬
等待開盤 08-10 09:30:00 美东时间
784.36
+12.250
+1.59%
華盛通- 最 高785.99
- 今 開774.47
- 成交量 83.76万股
- 最 低 767.17
- 昨 收 772.11
- 總市值 807.54亿
- 52周最高 819.23
- 市盈率 靜 18.91
- 換手率 0.81%
- 52周最低 538.24
- 委 比 40.21%
- 總股本 1.03亿
- 歷史最高 1205.7999
- 量 比 1.01
- 振 幅 2.44%
- 歷史最低 37.43
- 每 手 1
- 風險率 79.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SA Asks: What's the outlook for Big Pharma M&A?
Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY) was in merger talks with AstraZeneca (AZN), a development that was later denied by...
08-09 03:28
Intellia upgraded at Evercore ISI on nex-z hypothesis
Shares of Intellia Therapeutics (NTLA) traded higher in the premarket on Friday after Evercore ISI upgraded the gene-editing biotech to Outperform from Inline, citing the company’s latest findings on ...
08-07 20:30
CytomX 2026年第二季度财报：合作收入下降推动亏损扩大
CytomX 2026年第二季度营收141.8万美元，同比下降约92.4%，稀释每股亏损0.09美元，净亏损扩大至2,066.6万美元；季度末现金及投资为3.303亿美元。
08-07 01:38
CytomX 2026年第二季度财报：营收降至141.8万美元，研发投入上升
CytomX 2026年第二季度营收141.8万美元，同比下降92.4%；稀释每股亏损0.09美元，净亏损2066.6万美元。期末现金及投资3.303亿美元，Varseta-M继续推进。
08-06 21:14
Moderna rises after starting phase 1 trial of Ebola vaccine
Moderna (MRNA) said that the first patients have been immunized in a phase 1 Canadian trial examining its mRNA vaccine mRNA-1469 to prevent Bundibugyo ebolavirus (BDBV). About 80 healthy adult partici...
08-05 01:38
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
一封“拒信”引发的蝴蝶效应，他造出中国版抗体研发引擎
（来源：抗体圈） 此时纽约大学的免疫学博士后沈月雷也遇到了自己人生中的第一场危机，来自再生元的求职拒绝信。 手握亮眼的履历，满怀信心和期待加入全球抗体药物标...
08-04 10:13
6 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
08-04 01:35
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
CytomX Therapeutics, Inc. has appointed Alejandra Carvajal as its new Chief Legal Officer. With over two decades of legal experience in the biotechnology sector, Carvajal will support the company's strategic and operational initiatives. She previously served as Chief Legal Officer at Mersana Therapeutics and Momenta Pharmaceuticals. CytomX, a clinical-stage oncology-focused biopharmaceutical company, is advancing its PROBODY® therapeutic platform...
08-03 12:00
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
